GeneDx Non Operating Income Net Other from 2010 to 2025
| WGS Stock | 92.20 2.14 2.27% |
Non Operating Income Net Other | First Reported 2010-12-31 | Previous Quarter 65.5 M | Current Value 58.3 M | Quarterly Volatility 4 M |
Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Interest Income of 3.1 M, Depreciation And Amortization of 30.9 M or Interest Expense of 2.7 M, as well as many indicators such as Price To Sales Ratio of 3.98, Dividend Yield of 0.0 or PTB Ratio of 8.85. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.
GeneDx | Non Operating Income Net Other |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.